NKTX — NKARTA INC

Ownership history in GSK plc  ·  1 quarter on record

This page tracks every 13F SEC filing in which GSK plc reported a position in NKARTA INC (NKTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.73% (2025 Q4)
Avg. % of fund
0.73%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 3,150,732 — — 0.73% $5.8M $1.85
% of Fund (quarterly)    NKTX price (monthly, adj. close)

Other funds also holding NKTX

As of 2025 Q4 — sorted by position size

SR ONE CAPITAL MANAGEMENT, LP 3Y 0.87% Monaco Asset Management SAM 3Y 0.82% Samsara BioCapital, LLC 3Y 7Y 0.67% NEA Management Company, LLC 3Y 7Y 0.34% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.24% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.2% AWM Investment Company, Inc. 3Y 7Y 0.16% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.14% Samalin Investment Counsel, LLC 3Y 0.1% Forefront Analytics, LLC 3Y 7Y 0.07%
← Back to GSK plc Holdings